24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Pfizer, Moderna to Expand Vaccine Studies in Young ChildrenCan COVID Transmit Easily on Crowded School Buses?Kids Still Dying From Accidental Exposure to Fentanyl Pain PatchesWhen Are Head Injury Risks Highest for Young Soccer Players?Simple Step Gets More School Kids Eating Their VeggiesSurvey Finds U.S. Parents Split on COVID Vaccination for Kids Under 12Most Parents Clueless About Overuse Dangers to Young PitchersEven Young Children Can Have Breathing Issues During Sleep1.5 Million Kids Worldwide Lost Parent or Other Caregiver to COVID-19Severe COVID in Kids: Rare, but Brain Issues Can ResultPrescriptions for U.S. Kids Declined During PandemicHow Your Kid's Education Could Make You HealthierPediatricians' Group: All School Kids, Staff Should Continue to Wear MasksAny COVID Infection Leaves Strong Antibody Levels in KidsMake Summer Camp Safe for Your Child With Asthma, AllergiesDrowning Deaths for U.S. Kids Have Fallen 38% Since 1999Heart Troubles Ease Over Time in Kids With MIS-CHalf of U.S. Teens Plan to Get COVID Shot, But Can Numbers Go Higher?Parent's Words Key to Young Kids' Fears Around VaccinationSummer Drowning Deaths Can Happen Quickly: Know the FactsWhy Handwriting Still Beats Typing, Videos at Helping Folks LearnVaccinated Teachers, Students Can Skip Masks This Fall: CDCIs Your Kid a Fast or Slow Eater? Personality Might TellLockdown Weight Gain May Have Caused Surge in New Diabetes Cases in KidsWhy Do So Many Kids Never Get Swimming Lessons?Screen All Kids for Heart Problems, Pediatricians' Group SaysFast-Food Companies Spending More on Ads Aimed at YouthTreating Teachers' Depression Could Boost Young Students' Grades: StudyDirty Air in Pregnancy Might Raise Baby's Obesity RiskChild Drownings in U.S. Pools, Spas Are on the RiseAHA News: As the Pandemic Wanes, Get Kids on the Road to Good Health This SummerAllergy Treatment Crucial If Your Child Has AsthmaScientists Discover Rare Form of ALS That Can Strike KidsDebunking Myths That Have Some Parents Resisting COVID Vaccines for TeensBedtime With a Pet Won't Harm Your Kid's Sleep - and Might HelpMost Cases of MIS-C in Kids With COVID Resolve After 6 MonthsFetal Exposure to Ultra-Fine Air Pollution Could Raise Asthma RisksAHA News: Kids With Sleep Apnea Into Teen Years Could Develop High Blood PressureIs Your Child at Risk for Asthma?Number of U.S. Kids Hospitalized With COVID Is Likely Overcounted: StudyClues to Rare Disorder Affecting Kids With COVID-19Pandemic Caused Rise in Telemedicine Visits for Kids, But Will the Trend Continue?What Works Best to Ease Recurrent Ear Infections in Kids?Rural U.S. Schools Are Bringing Back In-Person Learning Faster Than Urban SchoolsIn Girls as Young as 7, Weight May Predict Odds for Eating DisorderRoad to Healthy Middle-Aged Brain May Begin in ChildhoodHow Summer Camps Can Shield Your Kids from Allergies, Asthma & COVIDCould Your Child Have a Heart Defect? Know the Warning SignsAir Pollution Can Harm Kids' Hearts for a LifetimePoll Finds Many Parents Hesitant to Get Younger Kids Vaccinated
Questions and AnswersLinks
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

FDA Approves First New Children's ADHD Drug in 10 Years

HealthDay News
by Robin Foster
Updated: Apr 6th 2021

new article illustration

TUESDAY, April 6, 2021 (HealthDay News) -- The first new drug developed in over a decade for children with attention deficit hyperactivity disorder (ADHD) has been approved by the U.S. Food and Drug Administration.

Qelbree, also known as viloxazine, comes in a capsule that is taken daily, and is not a stimulant. This makes it harder to abuse than older ADHD drugs, nearly all of which contain the stimulants amphetamine or methylphenidate.

Experts say the drug may appeal to parents who don't want to give their child stimulants.

It also could be an option for kids who already have substance abuse problems, dislike the side effects of stimulants or need additional therapy, Dr. David Goodman told the Associated Press. He's an assistant professor of psychiatry at Johns Hopkins School of Medicine in Baltimore.

Goodman said most ADHD patients are prescribed long-acting stimulants, which are harder to abuse to get a high than the original, fast-acting versions of these drugs. Developed by Supernus Pharmaceuticals of Rockville, Md., Qelbree carries a warning about the potential for suicidal thoughts and behavior, which occurred in fewer than 1% of volunteers in studies of the drug, the AP said.

Supernus wouldn't disclose the drug's list price, but it's sure to be higher than the many cheap generic ADHD pills on the market today, the AP said.

ADHD affects about 6 million American children and adolescents, according to the U.S. Centers for Disease Control and Prevention. For many, problems include trouble paying attention and completing tasks, fidgeting and impulsiveness.

In a late-stage study funded by Supernus, 477 children aged 6 to 11 took the drug for six weeks. Inattention and hyperactivity symptoms were reduced by about 50% compared to the placebo group, the AP reported. Qelbree helped reduce symptoms in some study volunteers within a week. Common side effects included sleepiness, lethargy, decreased appetite and headache.

Supernus is in late-stage testing of Qelbree for adults with ADHD, the AP said. It's in a much smaller group than children, but that market is growing because few adults currently take ADHD medicines.

Viloxazine was sold as an antidepressant in Europe for several decades, but was never approved by the FDA, the AP reported. The maker ended sales for business reasons nearly two decades ago, as popular pills such as Zoloft and Prozac came to dominate the market.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on ADHD.

SOURCE: Associated Press